Share on StockTwits

Exactech Inc. (NASDAQ:EXAC) issued an update on its FY14 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $1.19-1.23 for the period, compared to the Thomson Reuters consensus estimate of $1.21, ARN reports. The company issued revenue guidance of $249-253 million, compared to the consensus revenue estimate of $250.95 million.Exactech also updated its Q3 guidance to $0.24-0.26 EPS.

Exactech Inc. (NASDAQ:EXAC) traded up 2.38% during mid-day trading on Monday, hitting $22.78. 27,007 shares of the company’s stock traded hands. Exactech Inc. has a 52 week low of $18.34 and a 52 week high of $26.52. The stock’s 50-day moving average is $24.67 and its 200-day moving average is $23.31. The company has a market cap of $311.1 million and a price-to-earnings ratio of 19.69.

Exactech (NASDAQ:EXAC) last issued its quarterly earnings data on Monday, July 28th. The company reported $0.30 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.30. The company had revenue of $63.92 million for the quarter, compared to the consensus estimate of $63.80 million. During the same quarter in the previous year, the company posted $0.27 earnings per share. The company’s revenue for the quarter was up 5.4% on a year-over-year basis. On average, analysts predict that Exactech Inc. will post $1.21 earnings per share for the current fiscal year.

Exactech, Inc develops, manufactures and sells orthopedic implant devices, related surgical instruments and biological material and services to make patients more mobile.

Receive News & Ratings for Exactech Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.